Standout Papers

Cancer immunotherapy: moving beyond current vaccines 2004 2026 2011 2018 2.2k
  1. Cancer immunotherapy: moving beyond current vaccines (2004)
    Steven A. Rosenberg, James C. Yang et al. Nature Medicine
  2. Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2 (2010)
    Richard A. Morgan, James C. Yang et al. Molecular Therapy
  3. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer (2014)
    Eric Tran, Simon Turcotte et al. Science
  4. Adoptive cell transfer: a clinical path to effective cancer immunotherapy (2008)
    Steven A. Rosenberg, Nicholas P. Restifo et al. Nature reviews. Cancer
  5. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells (2011)
    James N. Kochenderfer, Mark E. Dudley et al. Blood
  6. A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer (2006)
    Michael H. Kershaw, Jennifer A. Westwood et al. Clinical Cancer Research
  7. Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma (2010)
    Richard E. Royal, Catherine Lévy et al. Journal of Immunotherapy
  8. Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction (1990)
    Steven A. Rosenberg, Paul Aebersold et al. New England Journal of Medicine
  9. T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis (2010)
    Maria R. Parkhurst, James C. Yang et al. Molecular Therapy
  10. Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma (2002)
    John Toso, Vee J. Gill et al. Journal of Clinical Oncology
  11. Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma (2019)
    Stephanie L. Goff, Richard A. Morgan et al. Journal of Immunotherapy

Immediate Impact

10 by Nobel laureates 44 from Science/Nature 204 standout
Sub-graph 1 of 12

Citing Papers

Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
Probiotic-guided CAR-T cells for solid tumor targeting
2023 StandoutScience
25 intermediate papers

Works of James C. Yang being referenced

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
2010 Standout
Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma
2002 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
James C. Yang 14905 11845 5634 135 20.4k
Mark E. Dudley 22980 19904 6685 113 28.7k
John R. Wunderlich 15486 14596 4734 121 20.7k
Richard A. Morgan 13054 7938 6922 120 18.3k
Maryalice Stetler‐Stevenson 8719 6069 4234 228 15.4k
Paul F. Robbins 19940 21066 8818 178 28.5k
Udai S. Kammula 13715 10107 4181 89 17.8k
Gianpietro Dotti 18657 10206 7479 284 25.6k
Renier J. Brentjens 14711 6602 5037 194 17.7k
Bruce L. Levine 22282 13718 9047 253 31.9k
Michael Kalos 11484 5916 4825 94 15.2k

All Works

Loading papers...

Rankless by CCL
2026